Telapristone

An orally available 21-substituted-19-nor-progestin and selective progesterone receptor modulator (SPRM), with potential anti-progesterone and antineoplastic activities. Upon oral administration, telapristone competitively binds to the progesterone receptor (PR) in progesterone-responsive tissue and inhibits PR-mediated gene expression. This interferes with progesterone activity in the reproductive system. As a result, this agent may suppress ovulation and inhibit proliferation of endometrial tissue. Also, this agent may prevent cell growth and induce apoptosis in estrogen receptor (ER) and PR-positive breast cancer cells through a reduction in progesterone levels, ER downregulation and a suppression of the expression of cyclin-dependent kinases (CDK) 2 and 4, ultimately leading to G1/S cell cycle arrest. Unlike some other SPRMs, this agent does not exert any estrogenic, androgenic, anti-estrogenic, and anti-androgenic activities. (NCI Thesaurus)

YOU MAY ALSO LIKE

Telaprevir

An orally available peptidomimetic small molecule with activity against hepatitis C virus (HCV). Telaprivir is a selective protease inhibitor that targets the…

Telangiectatic Osteosarcoma

An osteosarcoma usually arising in the metaphysis of long bones. It is characterized by the presence of a cystic architecture with blood-filled…

Telangiectatic Glomangioma

A glomus tumor characterized by huge vascular channel formations.

Telangiectasia

The permanent enlargement of blood vessels, causing redness in the skin or mucous membranes.

TEL-AML1 Fusion Protein Expression

Expression of a fusion protein containing the helix-loop-helix domain encoded by the human ETV6 gene and the DNA-binding and transactivation domains encoded…

TEK wt Allele

Human TEK wild-type allele is located within 9p21 and is approximately 121 kb in length. This allele, which encodes angiopoietin-1 receptor protein,…